dexmethylphenidate chemical structure
Find information on thousands of medical conditions and prescription drugs.

Focalin

Dexmethylphenidate (commercially known as Focalin) is a pharmaceutical drug used to treat Attention Deficit Hyperactivity Disorder. It is very similar to Ritalin, but it only contains the d-isomer of methylphenidate. It is a stimulant that affects the central nervous system. Dexmethylphenidate is a short acting drug, its half-life usually being between four and six hours.

Home
Diseases
Medicines
A
B
C
D
E
F
Captagon
Famohexal
Famotidine
Faslodex
Faslodex
Fasoracetam
Felbamate
Felbatol
Felodipine
Felypressin
Femara
Femara
Fempatch
Femring
Fenfluramine
Fenofibrate
Fentanyl
Fexofenadine
Filgrastim
Filipin
Finasteride
Fioricet
Fiorinal
Flagyl
Flarex
Flavoxate
Flecainide
Flexeril
Flomax
Flonase
Flovent
Floxuridine
Fluacizine
Flucloxacillin
Fluconazole
Flucytosine
Fludarabine
Fludrocortisone
Flumazenil
Flunisolide
Flunitrazepam
Fluocinonide
Fluohexal
Fluorometholone
Fluorouracil
Fluoxetine
Fluphenazine
Flurazepam
Flutamide
Fluticasone
Fluvastatin
Fluvoxamine
FML
Focalin
Folic acid
Follutein
Fomepizole
Formoterol
Fortamet
Fortovase
Fosamax
Fosinopril
Fosinoprilat
Fosmidomycin
Fosphenytoin
Frova
Frovatriptan
Frusehexal
Fulvestrant
Fumagillin
Furazolidone
Furosemide
Furoxone
Fusafungine
Fusidic acid
Fuzeon
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


New drugs, tools OKd to treat conditions
From Chicago Sun-Times, 4/21/02

A number of new drugs and diagnostic tools recently have been approved, or are on the horizon, to treat attention deficit/ hyperactivity disorder.

Adderall XR: This once-a-day version of Adderall was approved last year by the U.S. Food and Drug Administration.

Ampakine: Now under development by Cortex Pharmaceuticals Inc. as a treatment for Alzheimer's disease, a recent study found this drug might also alleviate some ADHD symptoms.

Atomoxetine: Eli Lilly is seeking federal approval for this nonstimulant treatment for ADHD.

Focalin: Approved last year, this new form of Ritalin reportedly can be given in small doses and lasts longer.

GW320659: Glaxo Wellcome Inc. announced more than a year ago that this drug was in development. Unlike most ADHD medications, it is not a stimulant.

MethyPatch: Noven Pharmaceuticals Inc. is developing a once-a-day patch that would deliver methylphenidate, the same drug used in products such as Ritalin.

OPTAx: The Optical Tracking and Attention Test is a relatively new diagnostic tool that measures how well a child can sit still and pay attention. While not the final word on whether a child has ADHD, it can help doctors determine if the problem exists and measure the success of medication, said Dr. Michael Feld, a psychiatrist who uses the system at Alexian Brothers Behavioral Health Hospital in Hoffman Estates.

Ritalin LA: This once-a-day formulation of Ritalin is awaiting final approval by the FDA.

Copyright The Chicago Sun-Times, Inc.
Provided by ProQuest Information and Learning Company. All rights Reserved.

Return to Focalin
Home Contact Resources Exchange Links ebay